Trials / Completed
CompletedNCT05552027
Minnesota HealthSolutions Cellular Car Seat Study
Sensor Network With Active Instructional Content to Prevent Child Safety Seat Misuse
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Minnesota HealthSolutions · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to evaluate an innovative child safety seat user engagement system (CCS system) designed to actively educate, instruct, and alarm caregivers with information associated with automatically-sensed safety seat misuses/errors via a smartphone application.
Detailed description
The primary objective of the study is to evaluate whether child safety seat users correct more critical misuse errors in child safety seat usage with the seat with the CCS system than the same seat with no sensor system. The CCS system will provide ongoing, tailored support to users at the time of an error. Videos will be available to users via a smartphone and provide short "how to" instructions that demonstrate how to correctly perform each safety seat behavior (e.g., tighten harness straps) and how to avoid common mistakes. The overall goal of the CCS system is to prevent child safety seat critical misuses and reduce deaths and injuries in children riding in motor vehicles. In the proposed study, adult participants will be asked to attend one in-person study visit and complete three (3) scenarios in which they will be asked to identify and correct errors in child safety seat use. Participants will be randomized to either the intervention group which will use the CCS system during each scenario or the control group which will not use the CCS system during each scenario.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CCS System- Prototype | Participants will be exposed to each of the 3 scenarios with the sensor system enabled (with feedback) |
| DEVICE | CCS System- Control | The participants will be exposed to each of the 3 scenarios with the system disabled (no feedback). |
Timeline
- Start date
- 2022-06-15
- Primary completion
- 2022-11-17
- Completion
- 2022-11-17
- First posted
- 2022-09-23
- Last updated
- 2024-09-19
- Results posted
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05552027. Inclusion in this directory is not an endorsement.